Key Record Dates
| ClinicalTrials.gov Identifier: | NCT02703272 |
|---|---|
| Brief Title: | A Safety and Efficacy Study of Ibrutinib in Pediatric and Young Adult Participants With Relapsed or Refractory Mature B-cell Non-Hodgkin Lymphoma |
| First Submitted : | March 3, 2016 |
| First Submitted that Met QC Criteria : | March 3, 2016 |
| First Posted : | March 9, 2016 (Estimate) |
| Results First Submitted : | June 10, 2022 |
| Results First Submitted that Met QC Criteria : | November 7, 2022 |
| Results First Posted : | December 2, 2022 |
| Last Update Submitted that Met QC Criteria : | November 7, 2022 |
| Last Update Posted : | December 2, 2022 |